Clarion News

2019 ESMO World GI Congress Highlights

SHARE:

Gastrointestinal cancers are the cause of approximately 40% of cancer deaths worldwide. The ESMO World Congress on Gastrointestinal Cancers (World GI) brings together a global community of clinicians, researchers, biopharmaceutical developers, and other experts to evaluate the latest innovations and future directions for tackling the unmet needs. We summarize below some of the key highlights including major advances in biomarker-directed targeted therapy, continued progress for immunotherapy, and continued optimization of chemotherapy.

 

Click HERE to read the full perspectives for the 2019 ESMO World GI Congress

Is Clarion the right place to advance your career?

Find out more about joining Clarion’s team of innovation advisors.

A life sciences strategy and organizational consultancy that collaborates with its clients to envision, craft and enable growth through innovation and leadership.